News

Metastatic Colorectal Cancer Clinical Trials and Studies 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
DelveInsight’s, “Metastatic Colorectal Cancer Pipeline Insight 2025” report provides comprehensive insights about 150+ ...
technologynetworks2d
Chemical Probe Reveals How Tuberculosis Evades Immunity
When M. tuberculosis is attacked by a host’s macrophage immune cells, the mycomembrane produces compounds that suppress the infected host’s immune response. Previously, Ben Swarts, Sloan Siegrist and ...
Medical Xpress4d
Light-activated probe reveals how tuberculosis evades immune defenses
When M. tuberculosis is attacked by a host's macrophage immune cells, the mycomembrane produces compounds that suppress the infected host's immune response. Previously, Ben Swarts, Sloan Siegrist ...
C&EN4d
A light-activated probe reveals TB immune system evasion mechanisms
When M. tuberculosis is attacked by a host’s macrophage immune cells, the mycomembrane produces compounds that suppress the infected host’s immune response. Previously, Ben Swarts, Sloan Siegrist and ...
Estimating complex immune cell structures by AI tools for survival prediction in advanced melanoma
Researchers from the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) have applied AI-driven processes for detecting tertiary ...
pharmaphorum3d
Gilead combs Shoreline for NK cell therapies in $2.3bn alliance
The two companies will collaborate on the development of targeted NK cell and macrophage cells derived from induced pluripotent stem cells (iPSC), cementing a relationship that has already seen ...